SHENZHEN, China & LOS ANGELES--(BUSINESS WIRE)--BioPharm Asia Inc. (OTCBB: BFAR), a rapidly growing pharmaceutical company in China, today announced that it has begun trading under the symbol “BFAR” on the Over-the-Counter Bulletin Board. The new symbol replaces “DOMR”, which the Company inherited in an earlier merger with the firm Domain Registration Corp.
